nach oben

Erschienen in:

08.12.2017

Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures

verfasst von: Jin-Shei Lai, Siera Goodnight, Nancy R. Downing, Rebecca E. Ready, Jane S. Paulsen, Anna L. Kratz, Julie C. Stout, Michael K. McCormack, David Cella, Christopher Ross, Jenna Russell, Noelle E. Carlozzi

Erschienen in: Quality of Life Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cognitive functioning impacts health-related quality of life (HRQOL) for individuals with Huntington disease (HD). The Neuro-QoL includes two patient-reported outcome (PRO) measures of cognition—Executive Function (EF) and General Concerns (GC). These measures have not previously been validated for use in HD. The purpose of this analysis is to evaluate the reliability and validity of the Neuro-QoL Cognitive Function measures for use in HD.

Methods

Five hundred ten individuals with prodromal or manifest HD completed the Neuro-QoL Cognition measures, two other PRO measures of HRQOL (WHODAS 2.0 and EQ5D), and a depression measure (PROMIS Depression). Measures of functioning The Total Functional Capacity and behavior (Problem Behaviors Assessment) were completed by clinician interview. Objective measures of cognition were obtained using clinician-administered Symbol Digit Modalities Test and the Stroop Test (Word, Color, and Interference). Self-rated, clinician-rated, and objective composite scores were developed. We examined the Neuro-QoL measures for reliability, convergent validity, discriminant validity, and known-groups validity.

Results

Excellent reliabilities (Cronbach’s alphas ≥ 0.94) were found. Convergent validity was supported, with strong relationships between self-reported measures of cognition. Discriminant validity was supported by less robust correlations between self-reported cognition and other constructs. Prodromal participants reported fewer cognitive problems than manifest groups, and early-stage HD participants reported fewer problems than late-stage HD participants.

Conclusions

The Neuro-QoL Cognition measures provide reliable and valid assessments of self-reported cognitive functioning for individuals with HD. Findings support the utility of these measures for assessing self-reported cognition.

Nur mit Berechtigung zugänglich

MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., & Groot, N. & Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983.CrossRef

Squitieri, F., Griguoli, A., Capelli, G., Porcellini, A., & D’Alessio, B. (2016). Epidemiology of Huntington disease: First post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89(3), 367–370.CrossRefPubMed

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed

Evans, S. J. W., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery & Psychiatry, 84(10), 1156–1160.CrossRef

Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J., & Smeeth, L. (2016). The prevalence of huntington’s disease. Neuroepidemiology, 46(2), 144–153.CrossRefPubMed

Paulsen, J. S. (2010). Early detection of Huntington’s disease. Future Neurology, 5(1), 85–104.CrossRef

Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225.CrossRefPubMed

U.S. Department of Health and Human Services. (2000). Healthy people 2010: Understanding and improving health (2nd ed.). Washington, DC: U.S. Government Printing Office.

Mickes, L., Jacobson, M., Peavy, G., Wixted, J. T., Lessig, S., Goldstein, J. L., & Corey-Bloom, J. (2010). A comparison of two brief screening measures of cognitive impairment in Huntington’s disease. Movement Disorders, 25(13), 2229–2233.CrossRefPubMed

10.

Stout, J. C., Glikmann-Johnston, Y., & Andrews, S. C. (2016). Cognitive assessment strategies in Huntington’s disease research. Journal of Neuroscience Methods, 265, 19–24.CrossRefPubMed

11.

Kremer, H. P. H. & Hungtington Study Group. (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11, 136–142.CrossRef

12.

Stout, J. C., Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B., Campbell, J. C., Carlozzi, N., Duff, K., Beglinger, L. J., Langbehn, D. R., Johnson, S. A., Biglan, K. M., & Aylward, E. H. (2011). Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25(1), 1–14.CrossRefPubMedPubMedCentral

13.

Smith, A. (1995). Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services.

14.

Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology-General, 121(1), 15–23.CrossRef

15.

Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662.CrossRef

16.

Benton, A. L., Sivan, A. B., Hamsher, K. D., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment (2nd ed.). New York: Oxford University Press.

17.

Conway, M. A. (1991). In defense of everyday memory. American Psychologist, 46(1), 19–26.CrossRef

18.

Loftus, E. F. (1991). The glitter of everyday memory … and the gold. American Psychologist, 46(1), 16–18.CrossRefPubMed

19.

Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13(4), 181–197.CrossRefPubMed

20.

Silver, C. H. (2000). Ecological validity of neuropsychological assessment in childhood traumatic brain injury. The Journal of Head Trauma Rehabilitation, 15(4), 973–988.CrossRefPubMed

21.

Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38(7), 926–934.CrossRefPubMed

22.

Cella, D., Lai, J. S., Nowinski, C., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavasos, J., Reder, A., Sufit, R., Simuni, T., Holmes, G., Siderowf, A., Wojna, V., Bode, R., McKinney, N., Podrabsky, T., Wortman, K., Choi, S., Gershon, R., Rothrock, N., & Moy, C. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology, 78, 1860–1867.CrossRefPubMedPubMedCentral

23.

Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., & Moy, C. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, 92(Suppl 1), S28-S36.PubMedCentral

24.

Hambleton, R. K., Swaminathan, H., & Rogers, H. J. (1991). Fundamentals of item response theory. Newbury Park, CA: SAGE Publications, Inc.

25.

Wright, B. D., & Masters, G. N. (1985). Rating scale analysis: Rasch measurement. Chicago: MESA Press.

26.

Perez, L., Huang, J., Jansky, L., Nowinski, C., Victorson, D., Peterman, A., & Cella, D. (2007). Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. Journal of Neuroscience Nursing, 39(6), 342–353.CrossRefPubMed

27.

Gershon, R., Lai, J., Bode, R., Choi, S., Moy, C., Bleck, T., Miller, D., Peterman, A., & Cella, D. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21(3), 475–486.CrossRefPubMed

28.

Rock, P., Roiser, J., Riedel, W., & Blackwell, A. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029.CrossRefPubMed

29.

Carlozzi, N. E., Schilling, S. G., Lai, J. S., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., Nance, M. A., Quaid, K. A., Stout, J. C., Gershon, R. C., Ready, R. E., Miner, J. A., Barton, S. K., Perlman, S. L., Rao, S. M., Frank, S., Shoulson, I., Marin, H., Geschwind, M. D., Dayalu, P., Goodnight, S. M., & Cella, D. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441–2455.CrossRefPubMed

30.

Shoulson, I., & Fahn, S. (1979). Huntington disease clinical care and evaluation. Neurology, 29(1), 1–1.CrossRefPubMed

31.

Marder, K., Zhao, H., Myers, R. H., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J. B. Jr., Siemers, E., Shoulson, I., & Huntington Study Group. (2000). Rate of functional decline in Huntington’s disease. Neurology, 54(2), 452–458.CrossRefPubMed

32.

Paulsen, J. S., Wang, C., Duff, K., Barker, R., Nance, M., Beglinger, L., Moser, D., Williams, J. K., Simpson, S., Langbehn, D., & van Kammen, D. P. (2010). Challenges assessing clinical endpoints in early Huntington disease. Movement Disorders, 25(15), 2595–2603.CrossRefPubMedPubMedCentral

33.

Hanauer, D. A., Mei, Q., Law, J., Khanna, R., & Zheng, K. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300.CrossRefPubMedPubMedCentral

34.

Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., Guttman, M., Nance, M., Kieburtz, K., Oakes, D., Shoulson, I., Kayson, E., Johnson, S., Penziner, E., & Investigators, P.-H. (2006). Preparing for preventive clinical trials—The Predict-HD study. Archives of Neurology, 63(6), 883–890.CrossRefPubMed

35.

Amtmann, D., Kim, J., Chung, H., Bamer, A. M., Askew, R. L., Wu, S., Cook, K. F., & Johnson, K. L. (2014). Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabilitation Psychology, 59(2), 220–229.CrossRefPubMedPubMedCentral

36.

Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., & Cella, D. (2011). Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS): Depression, anxiety, and anger. Assessment, 18(3), 263–283.CrossRefPubMedPubMedCentral

37.

Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., Dewalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Pilkonis, P., Revicki, D., Rose, M., Weinfurt, K., Hays, R., & Lai, J. S. & PROMIS Cooperative Group. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.CrossRefPubMedPubMedCentral

38.

Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007). The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH Roadmap Cooperative Group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11.

39.

Callaghan, J., Stopford, C., Arran, N., Boisse, M.-F., Coleman, A., Santos, R. D., Dumas, E. M., Hart, E. P., Justo, D., & Owen, G. (2015). Reliability and factor structure of the short problem behaviors assessment for Huntington’s disease (PBA-s) in the TRACK-HD and REGISTRY studies. Journal of Neuropsychiatry and Clinical Neurosciences, 27(1), 59–64.CrossRefPubMed

40.

Üstün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., Korff, M. v., & Pull, C. (2010). Developing the World Health Organization disability assessment schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.CrossRefPubMedPubMedCentral

41.

Carlozzi, N. E., Kratz, A. L., Downing, N. R., Goodnight, S., Miner, J. A., Migliore, N., & Paulsen, J. S. (2015). Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD). Quality of Life Research, 24(8), 1963–1971CrossRefPubMedPubMedCentral

42.

43.

Beglinger, L. J., O’Rourke, J. J., Wang, C., Langbehn, D. R., Duff, K., & Paulsen, J. S. (2010). Earliest functional declines in Huntington disease. Psychiatry Research, 178(2), 414–418.CrossRefPubMedPubMedCentral

44.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press.

45.

DeVellis, R. (2017). Scale development: Theory and applications (4th edn.). Los Angeles, CA: Sage.

46.

Cramer, D., & Howitt, D. L. (2004). The Sage dictionary of statistics. Thousand Oaks, CA: Sage.CrossRef

47.

Andresen, E. M. (2000). Criteria for assessing the tools of disability outcomes research. Archives of Physical Medicine & Rehabilitation, 81(12 Suppl 2), S15–S20.CrossRef

48.

Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.CrossRefPubMed

49.

Miles, J., & Shevlin, M. (2001). Applying regression and correlation: A guide for students and researchers. London: Sage Publications, Ltd.

50.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: L. Erlbaum Associates.

51.

Youngstrom, E. A. (2014). A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: We are ready to ROC. Journal of Pediatric Psychology, 39(2), 204–221.CrossRefPubMed

52.

Heaton, R. K., Miller, S. W., Taylor, J. T., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources, Inc.

53.

Grimes, D. A., & Schulz, K. F. (2005). Refining clinical diagnosis with likelihood ratios. The Lancet, 365(9469), 1500–1505.CrossRef

54.

Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed

55.

Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Aylward, E., Carlozzi, N. E., & Queller, S. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207.CrossRefPubMedPubMedCentral

56.

Lai, J.-S., Zelko, F., Krull, K., Cella, D., Nowinski, C., Manley, P., & Goldman, S. (2014). Parent-reported cognition of children with cancer and its potential clinical usefulness. Quality of Life Research, 23(4), 1049–1058.CrossRefPubMed

57.

Choi, S., Reise, S., Pilkonis, P., Hays, R., & Cella, D. (2010). Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Quality of Life Research, 19(1), 125–136.CrossRefPubMed

58.

Lai, J. S., Zelko, F., Butt, Z., Cella, D., Kieran, M. W., Krull, K. R., Magasi, S., & Goldman, S. (2011). Parent-perceived child cognitive function: Results from a sample drawn from the US general population. Child’s Nervous System, 27(2), 285–293.CrossRefPubMed

Titel: Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures
verfasst von: Jin-Shei Lai
Siera Goodnight
Nancy R. Downing
Rebecca E. Ready
Jane S. Paulsen
Anna L. Kratz
Julie C. Stout
Michael K. McCormack
David Cella
Christopher Ross
Jenna Russell
Noelle E. Carlozzi
Publikationsdatum: 08.12.2017
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 3/2018
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1755-6

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures

Abstract

Purpose

Methods

Results

Conclusions

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Computer assistive technology and associations with quality of life for individuals with spinal cord injury: a systematic review

The association between somatic and psychological discomfort and health-related quality of life according to the elderly and non-elderly

Understanding the need for assistance with survey completion in people with Huntington disease

Prospective associations of social isolation and loneliness with poor sleep quality in older adults

Health-related quality of life and recovery patterns among hospitalised injury patients in Vietnam

Casual effects of informal care and health on falls and other accidents among the elderly population in China